DE637236T1 - Pharmazeutische zubereitung und verfahren für ihre herstellung. - Google Patents
Pharmazeutische zubereitung und verfahren für ihre herstellung.Info
- Publication number
- DE637236T1 DE637236T1 DE0637236T DE93908973T DE637236T1 DE 637236 T1 DE637236 T1 DE 637236T1 DE 0637236 T DE0637236 T DE 0637236T DE 93908973 T DE93908973 T DE 93908973T DE 637236 T1 DE637236 T1 DE 637236T1
- Authority
- DE
- Germany
- Prior art keywords
- dissolves
- film
- agent according
- dichloromethylene
- diphosphonic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- ACSIXWWBWUQEHA-UHFFFAOYSA-N clodronic acid Chemical compound OP(O)(=O)C(Cl)(Cl)P(O)(O)=O ACSIXWWBWUQEHA-UHFFFAOYSA-N 0.000 claims abstract 5
- 150000003839 salts Chemical class 0.000 claims abstract 4
- 239000003795 chemical substances by application Substances 0.000 claims 5
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 claims 3
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 claims 3
- 229920000623 Cellulose acetate phthalate Polymers 0.000 claims 2
- 229940081734 cellulose acetate phthalate Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000012377 drug delivery Methods 0.000 claims 2
- 229920000639 hydroxypropylmethylcellulose acetate succinate Polymers 0.000 claims 2
- 229940100467 polyvinyl acetate phthalate Drugs 0.000 claims 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical class CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims 1
- ZUAAPNNKRHMPKG-UHFFFAOYSA-N acetic acid;butanedioic acid;methanol;propane-1,2-diol Chemical compound OC.CC(O)=O.CC(O)CO.OC(=O)CCC(O)=O ZUAAPNNKRHMPKG-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 229920002301 cellulose acetate Polymers 0.000 claims 1
- WZNRVWBKYDHTKI-UHFFFAOYSA-N cellulose, acetate 1,2,4-benzenetricarboxylate Chemical compound OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O.OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O.CC(=O)OCC1OC(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(COC(C)=O)O1.CC(=O)OCC1OC(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(COC(C)=O)O1.OC(=O)C1=CC(C(=O)O)=CC=C1C(=O)OCC1C(OC2C(C(OC(=O)C=3C(=CC(=CC=3)C(O)=O)C(O)=O)C(OC(=O)C=3C(=CC(=CC=3)C(O)=O)C(O)=O)C(COC(=O)C=3C(=CC(=CC=3)C(O)=O)C(O)=O)O2)OC(=O)C=2C(=CC(=CC=2)C(O)=O)C(O)=O)C(OC(=O)C=2C(=CC(=CC=2)C(O)=O)C(O)=O)C(OC(=O)C=2C(=CC(=CC=2)C(O)=O)C(O)=O)C(OC(=O)C=2C(=CC(=CC=2)C(O)=O)C(O)=O)O1 WZNRVWBKYDHTKI-UHFFFAOYSA-N 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 210000000936 intestine Anatomy 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000008188 pellet Substances 0.000 claims 1
- 229920002744 polyvinyl acetate phthalate Polymers 0.000 claims 1
- 125000005591 trimellitate group Chemical group 0.000 claims 1
- 239000013543 active substance Substances 0.000 abstract 1
- 229960002286 clodronic acid Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9201299A SE501389C2 (sv) | 1992-04-24 | 1992-04-24 | Farmaceutiskt preparat och förfarande för dess framställning |
| PCT/FI1993/000166 WO1993021907A1 (en) | 1992-04-24 | 1993-04-21 | Pharmaceutical preparation and process for its manufacture |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE637236T1 true DE637236T1 (de) | 1995-07-06 |
Family
ID=20386054
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE0637236T Pending DE637236T1 (de) | 1992-04-24 | 1993-04-21 | Pharmazeutische zubereitung und verfahren für ihre herstellung. |
| DE69305335T Expired - Fee Related DE69305335T2 (de) | 1992-04-24 | 1993-04-21 | Pharmazeutische zubereitung und verfahren für ihre herstellung |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69305335T Expired - Fee Related DE69305335T2 (de) | 1992-04-24 | 1993-04-21 | Pharmazeutische zubereitung und verfahren für ihre herstellung |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5525354A (https=) |
| EP (1) | EP0637236B1 (https=) |
| JP (1) | JP3536106B2 (https=) |
| AT (1) | ATE143802T1 (https=) |
| AU (1) | AU671830B2 (https=) |
| CA (1) | CA2134196C (https=) |
| CZ (1) | CZ282871B6 (https=) |
| DE (2) | DE637236T1 (https=) |
| DK (1) | DK0637236T3 (https=) |
| EE (1) | EE03107B1 (https=) |
| ES (1) | ES2094539T3 (https=) |
| FI (1) | FI110667B (https=) |
| GR (1) | GR3022249T3 (https=) |
| HK (1) | HK13097A (https=) |
| HU (1) | HU219342B (https=) |
| IL (1) | IL105403A (https=) |
| NO (1) | NO306654B1 (https=) |
| RU (1) | RU2116074C1 (https=) |
| SE (1) | SE501389C2 (https=) |
| TW (1) | TW273515B (https=) |
| WO (1) | WO1993021907A1 (https=) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6406714B1 (en) | 1992-12-02 | 2002-06-18 | Merck & Co., Inc. | Dry mix formulation for bisphosphonic acids |
| WO1994026310A1 (de) * | 1993-05-15 | 1994-11-24 | Boehringer Mannheim Gmbh | Tablette mit verbesserter bioverfügbarkeit enthaltend dichlormethylendiphosphonsäure als wirkstoff |
| US5431920A (en) * | 1993-09-21 | 1995-07-11 | Merck Frosst, Canada, Inc. | Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents |
| FI94926C (fi) * | 1993-11-12 | 1995-11-27 | Leiras Oy | Menetelmä klodronaattivalmisteen valmistamiseksi |
| US20010007863A1 (en) | 1998-06-18 | 2001-07-12 | Merck & Co., Inc. | Wet granulation formulation for bisphosphonic acids |
| TW390813B (en) * | 1994-04-29 | 2000-05-21 | Merck & Co Inc | Wet granulation formulation for bisphosphonic acids |
| FI98343C (fi) * | 1995-03-21 | 1997-06-10 | Orion Yhtymae Oy | Peroraalinen formulaatio |
| DE19719680A1 (de) | 1997-05-09 | 1998-11-19 | Boehringer Mannheim Gmbh | Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz |
| JPH11137208A (ja) * | 1997-11-14 | 1999-05-25 | Nikken Chem Co Ltd | 口腔内速溶性固形物及びその製造方法 |
| EP0998932A1 (de) * | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung |
| EP0998933A1 (de) * | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation |
| US7658938B2 (en) | 1999-02-22 | 2010-02-09 | Merrion Reasearch III Limited | Solid oral dosage form containing an enhancer |
| CA2363123C (en) * | 1999-02-22 | 2011-09-06 | Kenneth Iain Cumming | Solid oral dosage form containing an enhancer |
| SE9901272D0 (sv) * | 1999-04-09 | 1999-04-09 | Astra Ab | New improved formulation |
| US6562974B2 (en) | 2000-02-01 | 2003-05-13 | The Procter & Gamble Company | Process for making geminal bisphosphonates |
| US6410520B2 (en) | 2000-02-01 | 2002-06-25 | The Procter & Gamble Company | Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
| KR20030083725A (ko) * | 2001-03-01 | 2003-10-30 | 에미스페어 테크놀로지스, 인코포레이티드 | 비스포스포네이트 전달용 조성물 |
| EP1390383B1 (en) | 2001-05-11 | 2012-02-29 | Isis Pharmaceuticals, Inc. | Antisense permeation enhancers |
| AU4061702A (en) * | 2001-05-15 | 2003-04-03 | Mcneil-Ppc, Inc. | Dip coating compositions containing starch or dextrin |
| US20030070584A1 (en) * | 2001-05-15 | 2003-04-17 | Cynthia Gulian | Dip coating compositions containing cellulose ethers |
| US8309118B2 (en) * | 2001-09-28 | 2012-11-13 | Mcneil-Ppc, Inc. | Film forming compositions containing sucralose |
| US7429619B2 (en) * | 2002-08-02 | 2008-09-30 | Mcneil Consumer Healthcare | Polyacrylic film forming compositions |
| US20080287400A1 (en) | 2004-05-24 | 2008-11-20 | Richard John Dansereau | Low Dosage Forms Of Risedronate Or Its Salts |
| US20080286359A1 (en) | 2004-05-24 | 2008-11-20 | Richard John Dansereau | Low Dosage Forms Of Risedronate Or Its Salts |
| US7645460B2 (en) | 2004-05-24 | 2010-01-12 | The Procter & Gamble Company | Dosage forms of risedronate |
| US7645459B2 (en) | 2004-05-24 | 2010-01-12 | The Procter & Gamble Company | Dosage forms of bisphosphonates |
| US7862552B2 (en) * | 2005-05-09 | 2011-01-04 | Boston Scientific Scimed, Inc. | Medical devices for treating urological and uterine conditions |
| KR101191322B1 (ko) | 2006-04-07 | 2012-10-16 | 메리온 리서치 Ⅲ 리미티드 | 증진제를 함유하는 고형 경구용 투여 제형 |
| CN107096012A (zh) | 2008-05-07 | 2017-08-29 | 诺和诺德股份有限公司 | 肽的组合物及其制备方法 |
| DE102008022520A1 (de) * | 2008-05-07 | 2009-11-12 | Bayer Animal Health Gmbh | Feste Arzneimittelformulierung mit verzögerter Freisetzung |
| WO2011120033A1 (en) | 2010-03-26 | 2011-09-29 | Merrion Research Iii Limited | Pharmaceutical compositions of selective factor xa inhibitors for oral administration |
| EP2661273A4 (en) | 2011-01-07 | 2014-06-04 | Merrion Res Iii Ltd | IRON PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION |
| US10265384B2 (en) | 2015-01-29 | 2019-04-23 | Novo Nordisk A/S | Tablets comprising GLP-1 agonist and enteric coating |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57171428A (en) * | 1981-04-13 | 1982-10-22 | Sankyo Co Ltd | Preparation of coated solid preparation |
| ATE60711T1 (de) * | 1986-12-20 | 1991-02-15 | Boehringer Mannheim Gmbh | Clodronat-haltige arzneimittel und verfahren zur herstellung derselben. |
| JP2782691B2 (ja) * | 1987-09-29 | 1998-08-06 | ワーナー−ランバート・コンパニー | 腸溶製剤の安定化 |
| FR2629716B1 (fr) * | 1988-04-07 | 1991-07-19 | Sanofi Sa | Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique |
-
1992
- 1992-04-24 SE SE9201299A patent/SE501389C2/sv not_active IP Right Cessation
-
1993
- 1993-04-13 TW TW082102782A patent/TW273515B/zh active
- 1993-04-15 IL IL105403A patent/IL105403A/en not_active IP Right Cessation
- 1993-04-21 AU AU39550/93A patent/AU671830B2/en not_active Ceased
- 1993-04-21 DK DK93908973.6T patent/DK0637236T3/da active
- 1993-04-21 AT AT93908973T patent/ATE143802T1/de not_active IP Right Cessation
- 1993-04-21 DE DE0637236T patent/DE637236T1/de active Pending
- 1993-04-21 CA CA002134196A patent/CA2134196C/en not_active Expired - Fee Related
- 1993-04-21 RU RU94045950A patent/RU2116074C1/ru not_active IP Right Cessation
- 1993-04-21 US US08/318,650 patent/US5525354A/en not_active Expired - Lifetime
- 1993-04-21 ES ES93908973T patent/ES2094539T3/es not_active Expired - Lifetime
- 1993-04-21 CZ CZ942614A patent/CZ282871B6/cs not_active IP Right Cessation
- 1993-04-21 WO PCT/FI1993/000166 patent/WO1993021907A1/en not_active Ceased
- 1993-04-21 JP JP51895893A patent/JP3536106B2/ja not_active Expired - Fee Related
- 1993-04-21 HU HU9403067A patent/HU219342B/hu not_active IP Right Cessation
- 1993-04-21 EP EP93908973A patent/EP0637236B1/en not_active Expired - Lifetime
- 1993-04-21 DE DE69305335T patent/DE69305335T2/de not_active Expired - Fee Related
-
1994
- 1994-10-21 NO NO944001A patent/NO306654B1/no unknown
- 1994-10-21 FI FI944961A patent/FI110667B/fi active
- 1994-11-15 EE EE9400134A patent/EE03107B1/xx not_active IP Right Cessation
-
1997
- 1997-01-09 GR GR970400013T patent/GR3022249T3/el unknown
- 1997-02-05 HK HK13097A patent/HK13097A/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE637236T1 (de) | Pharmazeutische zubereitung und verfahren für ihre herstellung. | |
| EP0277127B1 (en) | New drug preparation with controlled release of the active compound, and a method for the manufacture thereof | |
| Waziri | Glycine therapy of schizophrenia. | |
| US6635680B2 (en) | Controlled release pellet formulation | |
| US5246714A (en) | Drug preparation | |
| DE69111832T2 (de) | Naproxen-Formulierung zur kontrollierten Absorption zur einmal täglichen Anwendung. | |
| US5320853A (en) | Controlled release formulation for pharmaceutical compounds | |
| DE247983T1 (de) | Arzneizubereitung zur oralen anwendung. | |
| PL323362A1 (en) | Method of treating inflammatory inteestine diseases using oral preparations of polyunsaturated omega-3 acids | |
| DE3585560D1 (de) | Arzneimittel in form einer einheitsdosis mit verzoegerter freisetzung sowie verfahren zu dessen herstellung. | |
| ATE19589T1 (de) | Pharmazeutische dreilagen-filmpraeparate mit lang anhaltender wirkung. | |
| JPS6296420A (ja) | 医薬製剤 | |
| HU908477D0 (en) | Process for the production of medical preparations with controlled content of active agents | |
| AU6764390A (en) | Pharmaceutical granules and drug dosage units made therefrom | |
| US7744924B2 (en) | Venlafaxine formulations and methods of preparing the same | |
| HK48194A (en) | Long-acting diclofenac sodium preparation | |
| KR100583065B1 (ko) | 프로그램화 및 펄스화 방출식 다립형 의약 제형 및 그의 제조 방법 | |
| HU9301672D0 (en) | Method for manufacturing solid dosing forms of medicaments with controlled releasing of active agents | |
| JP4160122B2 (ja) | 複数の連続する制御された放出を持った多粒子製薬形態の調製方法 | |
| DE3681334D1 (de) | Androstane-17-beta-carbonsaeureester, verfahren zu deren herstellung und pharmazeutische praeparate die diese enthalten. | |
| ATE56706T1 (de) | 4-methoxyisophthalsaeurederivat mit pharmakologischer wirksamkeit gegen thromboembolische erkrankung und verfahren zu dessen herstellung. | |
| CA1293449C (en) | Controlled release drug preparation | |
| DE3689086D1 (de) | 1,4-dihydropyridin-derivate, verfahren zu ihrer herstellung, pharmazeutische zusammensetzung und ihre verwendung. | |
| HK11494A (en) | New drug preparation with controlled release of the active compound, and a method for the manufacture thereof | |
| KR950002759A (ko) | 새로운 오메프라졸 경구 제형 |